1. Home
  2. VIR vs WEAV Comparison

VIR vs WEAV Comparison

Compare VIR & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • WEAV
  • Stock Information
  • Founded
  • VIR 2016
  • WEAV 2011
  • Country
  • VIR United States
  • WEAV United States
  • Employees
  • VIR N/A
  • WEAV N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • WEAV EDP Services
  • Sector
  • VIR Health Care
  • WEAV Technology
  • Exchange
  • VIR Nasdaq
  • WEAV Nasdaq
  • Market Cap
  • VIR 844.9M
  • WEAV 618.7M
  • IPO Year
  • VIR 2019
  • WEAV 2021
  • Fundamental
  • Price
  • VIR $5.41
  • WEAV $8.79
  • Analyst Decision
  • VIR Strong Buy
  • WEAV Strong Buy
  • Analyst Count
  • VIR 7
  • WEAV 5
  • Target Price
  • VIR $32.86
  • WEAV $16.10
  • AVG Volume (30 Days)
  • VIR 1.1M
  • WEAV 982.1K
  • Earning Date
  • VIR 07-31-2025
  • WEAV 07-30-2025
  • Dividend Yield
  • VIR N/A
  • WEAV N/A
  • EPS Growth
  • VIR N/A
  • WEAV N/A
  • EPS
  • VIR N/A
  • WEAV N/A
  • Revenue
  • VIR $20,861,000.00
  • WEAV $212,950,000.00
  • Revenue This Year
  • VIR N/A
  • WEAV $18.69
  • Revenue Next Year
  • VIR N/A
  • WEAV $15.71
  • P/E Ratio
  • VIR N/A
  • WEAV N/A
  • Revenue Growth
  • VIR N/A
  • WEAV 19.58
  • 52 Week Low
  • VIR $4.32
  • WEAV $7.91
  • 52 Week High
  • VIR $14.45
  • WEAV $17.63
  • Technical
  • Relative Strength Index (RSI)
  • VIR 55.40
  • WEAV 48.59
  • Support Level
  • VIR $4.91
  • WEAV $7.98
  • Resistance Level
  • VIR $5.35
  • WEAV $8.68
  • Average True Range (ATR)
  • VIR 0.25
  • WEAV 0.36
  • MACD
  • VIR 0.03
  • WEAV 0.05
  • Stochastic Oscillator
  • VIR 86.21
  • WEAV 85.44

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

Share on Social Networks: